Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Social Anxiety Disorder
Interventions
DRUG

D-Cycloserine

D-cycloserine is a medication thought to be associated with fear extinction.

DRUG

Placebo

Sugar pill

BEHAVIORAL

Cognitive Behavioral Therapy

This will be a 5-session version of a group CBT protocol with 4-6 patients and 2 therapists per group emphasizing repeated exposure practices. Session 1 involves an introduction and orientation to the CBT model. Sessions 2-5 emphasize repeated exposure tasks, which consist of role-play activities to confront fearful situations in a group setting while disputing cognitive distortions (coupled with the fading of safety behaviors). At the conclusion of each exposure session, patients will be encouraged to continue to apply home-practice strategies (such as giving speeches in front of a mirror). Continued practice of the interventions will be considered part of treatment, and patients will be asked to refrain from alternative treatment for four weeks following completion of the last treatment session.

Trial Locations (3)

60612

Rush University Medical Center, Chicago

78712

University of Texas at Austin, Austin

02215

Boston University, Boston

All Listed Sponsors
collaborator

Rush University Medical Center

OTHER

collaborator

Boston University

OTHER

collaborator

Southern Methodist University

OTHER

lead

University of Texas at Austin

OTHER

NCT02066792 - Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder | Biotech Hunter | Biotech Hunter